Stephen Davis - Net Worth and Insider Trading
Stephen Davis Net Worth
The estimated net worth of Stephen Davis is at least $3 Million dollars as of 2024-10-13. Stephen Davis is the CEO of ACADIA Pharmaceuticals Inc and owns about 186,555 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $3 Million. Details can be seen in Stephen Davis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Davis has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen Davis
Stephen Davis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Davis owns 3 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) , Heron Therapeutics Inc (HRTX) , and Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of Stephen Davis’s form 4 insider trades.
Insider Ownership Summary of Stephen Davis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-08-19 | director & PRESIDENT AND CEO |
| HRTX | Heron Therapeutics Inc | 2010-02-17 | director |
| BLCM | Bellicum Pharmaceuticals Inc | 2021-06-15 | director |
Stephen Davis Latest Holdings Summary
Stephen Davis currently owns a total of 1 stock. Stephen Davis owns 186,555 shares of ACADIA Pharmaceuticals Inc (ACAD) as of August 19, 2024, with a value of $3 Million.
Latest Holdings of Stephen Davis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-08-19 | 186,555 | 14.92 | 2,783,401 |
Holding Weightings of Stephen Davis
Stephen Davis Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Davis has made a total of 26 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 31,747 shares on August 19, 2024, which brought Stephen Davis around $485,094.
Insider Trading History of Stephen Davis
- 1
Stephen Davis Trading Performance
Stephen Davis Ownership Network
Stephen Davis Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Stephen Davis is the director & PRESIDENT AND CEO of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and Principal Accounting Officer James Kihara .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Stephen Davis made 10 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 327,742. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 42,451 shares made by Brendan Teehan , and a net sale of 17,522 shares made by James Kihara .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 464,616 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 431,906 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Stephen Davis Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Davis. You might contact Stephen Davis via mailing address: Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
